Media

partnering

TRIANNI is BioWorld’s Partner in Focus

TRIANNI is featured in BioWorld Today as a Partner in Focus. Read the feature here. The feature highlights: • Advantages […]

Continue reading

Transgenic Mice: Transforming Targeted Monoclonal Antibody (mAb) Therapeutics

Download Full Whitepaper Monoclonal antibodies (mAbs) currently represent the largest class of biopharmaceutical products. Market growth is projected to climb […]

Continue reading

Biopharma Dealmakers feature The Trianni Mouse Platform

Biopharma Dealmakers from the publishers of Nature, feature TRIANNI, Inc’s Trianni Mouse platform for the discovery of monoclonal antibodies. Read […]

Continue reading

ChemPartner and Trianni Announce Partnering Agreement

San Francisco, CA, USA., August 2, 2016 – Trianni, Inc. (“TRIANNI”) and ChemPartner, a leading science-driven, technologically advanced, high-quality preclinical […]

Continue reading

TRIANNI Announces Issuance of Patent in China

San Francisco, CA, USA., June 9, 2016 – Trianni, Inc. is pleased to announce that a patent for the Trianni […]

Continue reading

Nature Magazine Profiles TRIANNI

Download Full Feature |   In just a few short years, California-based  TRIANNI Inc. has emerged as one of the […]

Continue reading

TRIANNI Announces Partnering Agreement with Evotec

San Francisco, CA, USA., May 17, 2016 – Trianni, Inc. (“TRIANNI”) and Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: […]

Continue reading

TRIANNI and LakePharma Announce Strategic Technology Partnering Agreement

San Francisco and Belmont, CA, USA, {May 9, 2016} – Trianni, Inc., (TRIANNI)  a private biotech company developing novel antibody […]

Continue reading

TRIANNI Announces Issuance of Russian Federation Patent

SAN FRANCISCO, March 2, 2016 — Trianni, Inc. (TRIANNI) announces that key aspects of its human antibody mouse platform were issued […]

Continue reading

TRIANNI Announces BIO Asia International Conference Sponsorship

San Francisco, CA, USA., February 23, 2016 – TRIANNI, Inc. (“Trianni”), a biotechnology company with proprietary antibody discovery technology, announced […]

Continue reading